MSI Methylation Sciences

company

About

MSI Methylation Sciences is a biotechnology company that develops and markets S-Adenosyl Methionine.

  • 51 - 100

Details

Last Funding Type
Series A
Last Funding Money Raised
€13.50M
Industries
Biotechnology,Dietary Supplements,Medical,Therapeutics
Founded date
Jan 1, 2007
Number Of Employee
51 - 100
Operating Status
Active

MSI Methylation Sciences Inc. operates as a biotechnology company. The company develops and markets S-Adenosyl Methionine, a prescription drug used as a dietary supplement. MSI Methylation Sciences Inc. was founded in 2007 and is based in West Vancouver, Canada.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
€13.50M
MSI Methylation Sciences has raised a total of €13.50M in funding over 2 rounds. Their latest funding was raised on Sep 29, 2011 from a Series A round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Sep 29, 2011 Series A €13.50M 1 Detail

Investors

Number of Lead Investors
Number of Investors
1
MSI Methylation Sciences is funded by 1 investors. Working Opportunity Fund are the most recent investors.
Investor Name Lead Investor Funding Round
Working Opportunity Fund Series A